Building Trust: Clinical Trial Diversity

The groundbreaking medical research happening today is laying the foundation for a new golden era of medicine. Clinical trials are a vital step in not just ensuring that new innovations are effective, but that they work for all patients. 

On June 22, during The Atlantic’s Health Equity Summit, PhRMA hosted a conversation on clinical trial diversity. PhRMA COO Lori Reilly and Genentech Vice President and Chief Diversity Officer Quita Highsmith focused on the work Genentech has done to build diversity in clinical trials and the important lessons learned along the way.


June 22, 2021 at 11:00am ET


  • Lori M. Reilly, Chief Operating Officer, PhRMA
  • Quita Highsmith, Vice President and Chief Diversity Officer, Genentech


Watch the Event Segment Here





This website uses cookies and other tracking technologies to optimize performance, preferences, usage, and statistics. By clicking “Accept All”, you consent to store on your device the cookies and other tracking technologies that require consent. You can tailor or change your preferences by clicking “Manage My Cookies”. You can check our privacy policy for more information.